This is good news. But I had to re-read this to fully understand.
The terminology "Exclusive Worldwide License Agreement" always sounds amazing on the surface.
However, what they have done is basically obtained the Intellectual Property from PRSTRT and St. Jude. Further to this though is that a patent application has already been submitted.
This is another item they can stair-step to human trials. But this is not yet a promise of a sale, distribution, or otherwise.
"Revive, PRSTRT and St. Jude agreed to terms consistent with industry standards, including future payments based on clinical trial and revenue milestones."
One step closer on another item, but I will still be growing and holding.
News 
Market Data 
Discover 
AI
